Home » Mesynthes Obtains FDA 510(k) for Endoform Dermal Template
Mesynthes Obtains FDA 510(k) for Endoform Dermal Template
Mesynthes, a privately held regenerative medicine company, Tuesday announced
that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Endoform Dermal Template.
GEN
GEN
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May